References
- Chole RA. Cellular and subcellular events of bone resorption in human and experimental cholesteatoma: the role of osteoclasts. Laryngoscope 1984; 94: 76–95.
- Schena M, Shalon D, Davis RW, Brown PO. Quantitative monitoring of gene expression patterns with a complementary DNA microarray. Science 1995; 270: 467–70.
- Tanaka T, Jaradat SA, Lim MK, Kargul GJ, Wang X, Grahovac MJ, et al. Genome-wide expression profiling of mid-gestation placenta and embryo using a 15,000 mouse developmental cDNA microarray. Proc Natl Acad Sci USA 2000; 97: 9127–32.
- Elek J, Park K, Narayanan R. Microarray-based expression profiling in prostate tumors. In Vitro 2000; 14: 173–82.
- Puga A, Maier A, Medvedovix M. The transcriptional signature of dioxin in human hepatoma HepG2 cells. Biochem Pharmacol 2000; 60: 1129–42.
- Tokuriki M, Noda I, Saito T, Narita N, Sunaga H, Tsuzuki H, et al. Gene expression analysis of human middle ear cholesteatoma using complementary DNA arrays. Laryngoscope 2003; 113: 808–14.
- Park K, Moon SK, Choung YH, Choi HS. Expression of beta-defensins in human middle ear cholesteatoma. Acta Otolaryngol 2003; 123: 236–40.
- Harder J, Bartels J, Christophers E, Schroder JM. Isolation and characterization of human beta-defensin-3, a novel human inducible peptide antibiotic. J Biol Chem 2001; 276: 5707–13.
- Jack RS, Fan X, Bernheiden M, Rune G, Ehlers M, Webert A, et al. Lipopolysaccharide-binding protein is required to combat a murine gram-negative bacterial infection. Nature 1997; 389: 742–5.
- Lancaster CA, Peat N, Duhig T, Wilson D, Taylor-Papadi-mitriou J, Gendler SJ. Structure and expression of the human polymorphic epithelial mucin gene: an expressed VNTR unit. Biochem Biophys Res Commun 1990; 173: 1019–29.
- Park H, Hyun SW, Kim KC. Expression of MUC1 mucin gene by hamster tracheal surface epithelial cells in primary culture. Am J Respir Cell Mol Biol 1996; 15: 237–44.
- Li X, Wang L, Nunes DP, Troxler RF, Offiier GD. Proinflammatory cytokines up-regulate MUC1 gene expression in oral epithelial cells. Dent Res 2003; 82: 883–7.
- Chan I. The role of extracellular matrix protein 1 in human skin. Clin Exp Dermatol 2004; 29: 52–6.
- Wang L, Yu J, Ni J, Xu XM, Wang J, Ning H, et al. Extracellular matrix protein 1 (ECM1) is over-expressed in malignant epithelial tumors. Cancer Lett 2003; 200: 57–67.
- Moscatello DK, Santra M, Mann DM, McQuillan DJ, Wong AJ, Iozzo RV. Decorin suppresses tumor cell growth by activating the epidermal growth factor receptor. J Clin Invest 1998; 101: 406–12.
- Yan S, Sloane BF. Molecular regulation of human cathepsin B: implication in pathologies. Biol Chem 2003; 384: 845–54.
- Amar MS, Wishahi HF, Zakhary MM. Clinical and biochemical studies of bone destruction in cholesteatoma. J Laryngol Otol 1996; 110: 534–9.
- Toomes C, James J, Wood A, Wu CL, McCormick D, Lench N, et al. Loss-of-function mutations in the cathepsin C gene result in periodontal disease and palmoplantar keratosis. Nat Genet 1999; 23: 421–4.
- Popescu NC, Bowden PE, DiPaolo JA. Two type II keratin genes are localized on human chromosome 12. Hum Genet 1989; 82: 109–12.
- Romano V, Raimondi E, Bosco P, Feo S, Di Pietro C, Leube RE, et al. Chromosomal mapping of human cytokeratin 13 gene (KRT13). Genomics 1992; 14: 495–7.
- Eckert RL. Sequence of the human 40-kDa keratin reveals an unusual structure with very high sequence identity to the corresponding bovine keratin. Proc Natl Acad Sci USA 1988; 85: 1114–8.
- Kim HJ, Tinling SP, Chole RA. Increased proliferation and migration of epithelium in advancing experimental cholesteatomas. Otol Neurotol 2002; 23: 840–4.